Abound Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96K | Hold |
28
| – | – | ﹤0.01% | 750 |
|
|
2025
Q1 | $2.06K | Sell |
28
-7
| -20% | -$515 | ﹤0.01% | 698 |
|
|
2024
Q4 | $2.29K | Sell |
35
-193
| -85% | -$12.7K | ﹤0.01% | 660 |
|
|
2024
Q3 | $17.8K | Sell |
228
-12
| -5% | -$937 | 0.01% | 317 |
|
|
2024
Q2 | $18.8K | Buy |
240
+1
| +0.4% | +$78 | 0.01% | 261 |
|
|
2024
Q1 | $16.2K | Sell |
239
-1
| -0.4% | -$68 | 0.01% | 288 |
|
|
2023
Q4 | $16.2K | Buy |
240
+2
| +0.8% | +$135 | 0.01% | 302 |
|
|
2023
Q3 | $16.1K | Hold |
238
| – | – | 0.01% | 247 |
|
|
2023
Q2 | $17.1K | Buy |
238
+47
| +25% | +$3.37K | 0.01% | 238 |
|
|
2023
Q1 | $13.3K | Hold |
191
| – | – | 0.01% | 251 |
|
|
2022
Q4 | $13K | Sell |
191
-120
| -39% | -$8.16K | 0.01% | 227 |
|
|
2022
Q3 | $17.1K | Buy |
+311
| New | +$17.1K | 0.01% | 211 |
|